In general, rebound isolates either retained (if cross-resistant at baseline) or developed significant cross-resistance to indinavir, saquinavir and atazanavir.
133, 3 mg lopinaviiri ja 33, 3 mg ritonaviiri (farmakokineetiline tugevdaja).